Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Commission's public consultation on electromagnetic effects on human health:

This article was originally published in Clinica

Executive Summary

November 3 is the deadline by which interested parties must send their comments to the European Commission's Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) on its preliminary opinion on the possible effects of electromagnetic fields (EMF) on human health, including those produced by medical equipment. The Commission intends to prepare a report to the Council and has asked the SCENIHR to update a previous official EU opinion in this area, as well as to monitor new information that may influence the assessment of risks to human health in this area.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT053262

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel